Filed: 5/15/2023ACC: 0001420506-23-001081
📋 What this filing means
SILVERARC CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 72 equity positions with a total reported market value of $242.25M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
72
Positions
$242.25M
Total AUM (reported)
27.50M
Total Shares
Allocation by class
EQUITIES$222.53M91.9%
LONG OPTION CALLS$19.71M8.1%
WARRANTS$11.5K0.0%
Portfolio Concentration
Top 3$31.74M13.1%
4–10$53.44M22.1%
11–25$78.75M32.5%
Rest$78.32M32.3%
Top 3 weight
13.1%
Top 10 weight
35.2%
Voting Authority Distribution
Total shares with voting rights: 27.50M
Sole
Full voting authority
27.50M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole72
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings72
Rows:
Merus NV
SOLEShares668.78K
TypeSH
Market value$12.31M
5.08%
Sole
668.78K
Shared
0.00
None
0.00
MacroGenics Inc
SOLEShares1.36M
TypeSH
Market value$9.76M
4.03%
Sole
1.36M
Shared
0.00
None
0.00
Viewray Inc
SOLEShares2.79M
TypeSH
Market value$9.67M
3.99%
Sole
2.79M
Shared
0.00
None
0.00
Poseida Therapeutics Inc
SOLEShares2.69M
TypeSH
Market value$8.28M
3.42%
Sole
2.69M
Shared
0.00
None
0.00
Oric Pharmaceuticals Inc
SOLEShares1.44M
TypeSH
Market value$8.18M
3.38%
Sole
1.44M
Shared
0.00
None
0.00
Terns Pharmaceuticals Inc
SOLEShares667.92K
TypeSH
Market value$7.91M
3.26%
Sole
667.92K
Shared
0.00
None
0.00
Akero Therapeutics Inc
SOLEShares202.56K
TypeSH
Market value$7.75M
3.20%
Sole
202.56K
Shared
0.00
None
0.00
Nuvalent Inc
SOLEShares281.53K
TypeSH
Market value$7.35M
3.03%
Sole
281.53K
Shared
0.00
None
0.00
Bellus Health Inc
SOLEShares1M
TypeSH
Market value$7.20M
2.97%
Sole
1M
Shared
0.00
None
0.00
Intra-Cellular Therapies Inc
SOLEShares125.03K
TypeSH
Market value$6.77M
2.79%
Sole
125.03K
Shared
0.00
None
0.00
89bio Inc
SOLEShares438.21K
TypeSH
Market value$6.67M
2.75%
Sole
438.21K
Shared
0.00
None
0.00
Viking Therapeutics Inc
SOLEShares380K
TypeSH
Market value$6.33M
2.61%
Sole
380K
Shared
0.00
None
0.00
Cogent Biosciences Inc
SOLEShares579.26K
TypeSH
Market value$6.25M
2.58%
Sole
579.26K
Shared
0.00
None
0.00
Karyopharm Therapeutics Inc
SOLEShares1.54M
TypeSH
Market value$6.00M
2.48%
Sole
1.54M
Shared
0.00
None
0.00
KalVista Pharmaceuticals Inc
SOLEShares723.54K
TypeSH
Market value$5.69M
2.35%
Sole
723.54K
Shared
0.00
None
0.00
Schrodinger Inc
SOLEShares212.82K
TypeSH
Market value$5.60M
2.31%
Sole
212.82K
Shared
0.00
None
0.00
Pliant Therapeutics, Inc
SOLEShares199.60K
TypeSH
Market value$5.31M
2.19%
Sole
199.60K
Shared
0.00
None
0.00
Aclaris Therapeutics, Inc
SOLEShares651.40K
TypeSH
Market value$5.27M
2.18%
Sole
651.40K
Shared
0.00
None
0.00
Gilead Sciences Inc
SOLEShares60.13K
TypeSH
Market value$4.99M
2.06%
Sole
60.13K
Shared
0.00
None
0.00
BioCryst Pharmaceuticals Inc
SOLEShares577.76K
TypeSH
Market value$4.82M
1.99%
Sole
577.76K
Shared
0.00
None
0.00
Veracyte Inc
SOLEShares209.65K
TypeSH
Market value$4.68M
1.93%
Sole
209.65K
Shared
0.00
None
0.00
Pharvaris NV
SOLEShares559.39K
TypeSH
Market value$4.51M
1.86%
Sole
559.39K
Shared
0.00
None
0.00
ImmunoGen, Inc
SOLEShares1.13M
TypeSH
Market value$4.33M
1.79%
Sole
1.13M
Shared
0.00
None
0.00
United Therapeutics Corp
SOLEShares18.58K
TypeSH
Market value$4.16M
1.72%
Sole
18.58K
Shared
0.00
None
0.00
Vertex Pharmaceuticals Inc
SOLEShares13.18K
TypeSH
Market value$4.15M
1.71%
Sole
13.18K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Merus NVSOLE | EQUITIES | 668.78K | SH | $12.31M 5.08% | 668.78K | 0.00 | 0.00 |
MacroGenics IncSOLE | EQUITIES | 1.36M | SH | $9.76M 4.03% | 1.36M | 0.00 | 0.00 |
Viewray IncSOLE | EQUITIES | 2.79M | SH | $9.67M 3.99% | 2.79M | 0.00 | 0.00 |
Poseida Therapeutics IncSOLE | EQUITIES | 2.69M | SH | $8.28M 3.42% | 2.69M | 0.00 | 0.00 |
Oric Pharmaceuticals IncSOLE | EQUITIES | 1.44M | SH | $8.18M 3.38% | 1.44M | 0.00 | 0.00 |
Terns Pharmaceuticals IncSOLE | EQUITIES | 667.92K | SH | $7.91M 3.26% | 667.92K | 0.00 | 0.00 |
Akero Therapeutics IncSOLE | EQUITIES | 202.56K | SH | $7.75M 3.20% | 202.56K | 0.00 | 0.00 |
Nuvalent IncSOLE | EQUITIES | 281.53K | SH | $7.35M 3.03% | 281.53K | 0.00 | 0.00 |
Bellus Health IncSOLE | EQUITIES | 1M | SH | $7.20M 2.97% | 1M | 0.00 | 0.00 |
Intra-Cellular Therapies IncSOLE | EQUITIES | 125.03K | SH | $6.77M 2.79% | 125.03K | 0.00 | 0.00 |
89bio IncSOLE | EQUITIES | 438.21K | SH | $6.67M 2.75% | 438.21K | 0.00 | 0.00 |
Viking Therapeutics IncSOLE | EQUITIES | 380K | SH | $6.33M 2.61% | 380K | 0.00 | 0.00 |
Cogent Biosciences IncSOLE | EQUITIES | 579.26K | SH | $6.25M 2.58% | 579.26K | 0.00 | 0.00 |
Karyopharm Therapeutics IncSOLE | EQUITIES | 1.54M | SH | $6.00M 2.48% | 1.54M | 0.00 | 0.00 |
KalVista Pharmaceuticals IncSOLE | EQUITIES | 723.54K | SH | $5.69M 2.35% | 723.54K | 0.00 | 0.00 |
Schrodinger IncSOLE | EQUITIES | 212.82K | SH | $5.60M 2.31% | 212.82K | 0.00 | 0.00 |
Pliant Therapeutics, IncSOLE | LONG OPTION CALLS | 199.60K | SH | $5.31M 2.19% | 199.60K | 0.00 | 0.00 |
Aclaris Therapeutics, IncSOLE | LONG OPTION CALLS | 651.40K | SH | $5.27M 2.18% | 651.40K | 0.00 | 0.00 |
Gilead Sciences IncSOLE | EQUITIES | 60.13K | SH | $4.99M 2.06% | 60.13K | 0.00 | 0.00 |
BioCryst Pharmaceuticals IncSOLE | EQUITIES | 577.76K | SH | $4.82M 1.99% | 577.76K | 0.00 | 0.00 |
Veracyte IncSOLE | EQUITIES | 209.65K | SH | $4.68M 1.93% | 209.65K | 0.00 | 0.00 |
Pharvaris NVSOLE | EQUITIES | 559.39K | SH | $4.51M 1.86% | 559.39K | 0.00 | 0.00 |
ImmunoGen, IncSOLE | LONG OPTION CALLS | 1.13M | SH | $4.33M 1.79% | 1.13M | 0.00 | 0.00 |
United Therapeutics CorpSOLE | EQUITIES | 18.58K | SH | $4.16M 1.72% | 18.58K | 0.00 | 0.00 |
Vertex Pharmaceuticals IncSOLE | EQUITIES | 13.18K | SH | $4.15M 1.71% | 13.18K | 0.00 | 0.00 |
Page 1 of 3